Ovid Therapeutics Inc Files For Mixed Shelf Of Up To $250M
Portfolio Pulse from Benzinga Newsdesk
Ovid Therapeutics Inc has filed for a mixed shelf offering of up to $250 million, according to a SEC filing.
November 03, 2023 | 8:12 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Ovid Therapeutics Inc's filing for a mixed shelf offering of up to $250 million could potentially dilute existing shares, impacting the stock price.
A mixed shelf offering allows a company to issue various types of securities such as stocks, bonds, etc. This could lead to dilution of existing shares, potentially causing the stock price to drop in the short term. However, it also provides the company with flexibility to raise funds as needed, which could be beneficial in the long term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100